Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Pac...
https://pubmed.ncbi.nlm.nih.gov/37643542/
Purpose: In randomized trials the combination of cisplatin and paclitaxel was superior to cisplatin and cyclophosphamide in advanced-stage epithelial ovarian cancer. Although in nonrandomized trials, carboplatin and paclitaxel was a less toxic and highly active combinat …
